Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an automated system to calculate metabolic tumor volume in diffuse large B-cell lymphoma. These findings could make it easier to calculate tumor volume for clinical trials and possibly patient care.
True innovation in healthcare requires us to look beyond the obvious. For years, DNA sequencing has been the key pillar of precision medicine, offering insights into disease predispositions, mechanisms, and diagnosis that inform treatment.
